About Us
 

CreaGen Biosciences is a 10 year drug discovery medchem firm with extensive experience in lead generation, lead optimization, natural products scaffolds, building block synthesis, custom library development, structure and fragment based drug design, and HTP parallel synthesis and purification.

CreaGen is located in Woburn, MA, just 8 miles (15 minutes) north of Cambridge, Massachusetts, the hub of the most robust life sciences cluster in the world. Massachusetts is the home to over 500 pharmaceutical and biotechnology companies along with world renowned academic research institutions.

CreaGen's fully automated chemistry facility with ICOS® platform is a true drug discovery organization with a 10 year track record of supporting academia researchers, emerging companies, established biotechs, and big pharmaceutical organizations. Our flexible business model allows the ability to FTE-base, Project-base or offer shared risk opportunities with our clients. Unlike most chemistry service providers, CreaGen conveys a true 'partnership approach' to our client's.

Our scientists are creative and highly skilled with extensive experience in a broad range of therapeutic areas and skills. With over 100 years of combined drug discovery and medicinal chemistry expertise, CreaGen scientists offer our partners an excellent and unmatched opportunity to expand their core business on a fast track while significantly reducing overhead costs.

CreaGen Services Include:

  • Medicinal Chemistry
  • Lead Generation
  • Lead Optimization
  • Scaffold/Building Block Synthesis
  • High Throughput Purification and Analysis
  • LCMS
  • NMR
  • In vitro and in vivo Screening assays
  • Fully equipped Chemistry Laboratory Incubator Facility

 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
    7th Advances In Chemical Sciences Symposium: May 4th, 2018
The Seventh Annual Advances in Chemical Sciences Symposium Royal Sonesta Hotel Cambridge, MA: May 4th, 2018 A day-long symposium focused on Medicinal Chemistry, Organic Synthesis, and Methodology, featuring eminent scientists from industry and academia. Speakers: Professor Richard R. Schrock (MIT): “TBA” Professor Dale L. Boger (Scripps Research Institute): “Redesign of Vancomycin for Resistant Bacteria” Professor Laura Kiessling (MIT): “TBA” Dr. Sue Ashwell (Forma Therapeutics): “Discovery and Optimization of a Novel Series of Inhibitors of mt-IDH1” Dr. Michael Hoemann (Abbvie): “Discovery and Optimization of Spleen Tyrosine Kinase Inhibitors for Immunological Diseases” Dr. Frank Salituro (Sage Therapeutics): “Discovery and Clinical Development of SAGE-217: A Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (GABA)A Receptor” Plus: Vendor Exhibition Hall and Networking Reception   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.